ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:ImmunoGen Inc (IMGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013835
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer including ovarian cancer, solid tumors, endometrial cancer, multiple myeloma, glioblastoma, breast, and bladder cancer. ImmunoGen also licenses its ADC technology to its partner pharmaceutical companies to develop anticancer compounds. The company focuses its research on evaluation of new targets, new antibodies, linkers and cytotoxic agents, advancement of internal product candidates through clinical trials, and others. ImmunoGen is headquartered in Waltham, Massachusetts, the US.

ImmunoGen Inc (IMGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImmunoGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ImmunoGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ImmunoGen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ImmunoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ImmunoGen Inc, Medical Equipment, Deal Details 10
Partnerships 10
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 10
Equity Offering 11
ImmunoGen Raises USD108.4 Million in Public Offering of Shares 11
ImmunoGen Plans to Raise up to USD50 Million in Public Offering 13
ImmunoGen Inc – Key Competitors 14
ImmunoGen Inc – Key Employees 15
ImmunoGen Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 03, 2017: ImmunoGen Reports Recent Progress and Third Quarter 2017 Operating Results 17
Jul 28, 2017: ImmunoGen Reports Recent Progress and Second Quarter 2017 Operating Results 19
May 05, 2017: ImmunoGen Reports Recent Progress and First Quarter 2017 Operating Results 21
Feb 17, 2017: ImmunoGen Reports Recent Progress and Operating Results for Six-Month Period and Quarter Ended December 31, 2016 23
Oct 28, 2016: ImmunoGen Reports Financial Results for Quarter Ended September 30 and Reviews Business Highlights 25
Aug 04, 2016: ImmunoGen Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Quarterly Business Update 27
Apr 29, 2016: ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update 29
Jan 29, 2016: ImmunoGen Reports Second Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update 30
Corporate Communications 32
Jan 23, 2017: ImmunoGen Announces Departure of Sandra Poole 32
Aug 09, 2016: ImmunoGen Announces Departure of Chief Development Officer 33
Apr 26, 2016: ImmunoGen Appoints Mark J. Enyedy as President and Chief Executive Officer 34
Apr 05, 2016: Daniel Junius to Retire as President and CEO of ImmunoGen 35
Other Significant Developments 36
Sep 29, 2016: ImmunoGen Completes Strategic Review to Strengthen the Organization and Drive Long-Term Growth 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
ImmunoGen Inc, Medical Equipment, Key Facts, 2016 2
ImmunoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ImmunoGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ImmunoGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ImmunoGen Inc, Deals By Market, 2011 to YTD 2017 8
ImmunoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 10
ImmunoGen Raises USD108.4 Million in Public Offering of Shares 11
ImmunoGen Plans to Raise up to USD50 Million in Public Offering 13
ImmunoGen Inc, Key Competitors 14
ImmunoGen Inc, Key Employees 15
ImmunoGen Inc, Subsidiaries 16

★海外企業調査レポート[ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NTPC Ltd (NTPC):電力:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Stresau Laboratory, Inc.:企業の戦略・SWOT・財務情報
    Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • KLM Catering Services Schiphol bv:企業の戦略・SWOT・財務分析
    KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report Summary KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Auris Medical Holding Ltd (EARS):企業の財務・戦略的SWOT分析
    Auris Medical Holding Ltd (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PhaseBio Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    PhaseBio Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PhaseBio Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Edinburgh Molecular Imaging Ltd:製品パイプライン分析
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a clinical phase biotechnology company that develops optical molecular imaging technology. It is involved in the discovery and development of small molecules and peptides. The company designs agents to improve the diagnosis and treatment of can …
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • Transgene SA (TNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …
  • Greatcell Solar Ltd (GSL)-エネルギー分野:企業M&A・提携分析
    Summary Greatcell Solar Ltd (Greatcell Solar), formerly Dyesol Limited, is a renewable energy company that develops and commercializes Perovskite Solar Cells (PSC) or solid-state dye solar cell (DSC), the third generation photovoltaic technology. The company develops a range of PSC chemicals, compon …
  • Latvenergo AS-エネルギー分野:企業M&A・提携分析
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務分析
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Railway Group Ltd:企業の戦略・SWOT・財務情報
    China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alesi Surgical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Alesi Surgical Ltd (Alesi Surgical), formerly Asalus Medical Instruments Ltd, is a medical device company that develops and markets laparoscopic surgical smoke handling systems. The company offers Ultravision, a system that removes laparoscopic surgical smoke without the need for gas exchang …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆